# Providing Regulatory Submissions in Electronic Format; General Considerations - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/providing-regulatory-submissions-in-electronic-format-general-considerations/09112e28-964d-4af6-8d59-7a42a1aab244

> FDA guidance document: Providing Regulatory Submissions in Electronic Format; General Considerations. Issue date: January 28, 1999. Get complete insights and analysis.

---

## Details

- Title: Providing Regulatory Submissions in Electronic Format; General Considerations
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1999-01-28
- Last Changed: 2020-05-15

## Related Documents

- [Monoclonal Antibodies Used as Reagents in Drug Manufacturing](https://www.globalkeysolutions.net/guidances/guidance-document/monoclonal-antibodies-used-as-reagents-in-drug-manufacturing/0b94c7da-8ce4-43bf-b6e2-89d4d67b6f23)
- [E9 Statistical Principles for Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/e9-statistical-principles-for-clinical-trials/d427b5ed-dd16-417e-adc2-9f35d3a3df23)
- [Providing Regulatory Submissions in Electronic Format — Content of Labeling](https://www.globalkeysolutions.net/guidances/guidance-document/providing-regulatory-submissions-in-electronic-format-content-of-labeling/23ae1483-3f18-4d5b-b4f8-4d2b84de3d6e)